05:43 PM EST, 01/13/2026 (MT Newswires) -- Marshall Urist, Executive Vice President, Research & Investments, on January 09, 2026, sold 20,000 shares in Royalty Pharma ( RPRX ) for $815,634. Following the Form 4 filing with the SEC, Urist has control over a total of 86,418 Class A ordinary shares of the company, with 7,398 shares held directly and 79,020 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1802768/000183813926000004/xslF345X05/wk-form4_1768343862.xml